The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20060631
The Journal of Experimental Medicine, Vol. 204, No. 4, 907-920
The Rockefeller University Press, 0022-1007 $30.00
© Masuda et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4961K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuda, A.
Right arrow Articles by Takai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuda, A.
Right arrow Articles by Takai, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation

Ai Masuda, Akira Nakamura, Tsutomu Maeda, Yuzuru Sakamoto, and Toshiyuki Takai

Department of Experimental Immunology and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai-shi 980-8575, Japan

CORRESPONDENCE Toshiyuki Takai: tostakai{at}idac.tohoku.ac.jp

Allergy is caused by immune effector cells, including mast cells and basophils. Cellular signaling that activates these effector cells is regulated by different inhibitory receptors on their surface. We show that human leukocyte immunoglobulin (Ig)-like receptor (LILR) B2 and its mouse orthologue, paired Ig-like receptor (PIR)–B, constitutively associate to major histocompatibility complex (MHC) class I on the same cell surface (in cis). The IgE-mediated effector responses were augmented in ß2-microglobulin 2m) and PIR-B–deficient mast cells. In addition, the increased cytokine production of ß2m-deficient mast cells was not affected by the co-culture with MHC class I–positive mast cells, showing that less cis interaction between PIR-B and MHC class I on mast cells led to the increased cytokine release. Thus, the constitutive cis binding between LILRB2 or PIR-B and MHC class I has an essential role in regulating allergic responses.


Abbreviations used: BMMC, bone marrow–derived mast cell; ß2m, ß2-microglobulin; Fc{varepsilon}RI, high affinity FcR for IgE; Fc{gamma}RIIB and Fc{gamma}RIII, type IIB and type III, respectively, low affinity FcR for IgG; FRET, fluorescence resonance energy transfer; HRP, horseradish peroxidase; ITAM, immunoreceptor tyrosine–based activation motif; ITIM, immunoreceptor tyrosine–based inhibition motif; LILR, leukocyte Ig-like receptor; MIP, macrophage inflammatory protein; PIR, paired Ig-like receptor; PLC, phospholipase C; PMT, photomultiplier; SHP, Src homology domain 2–containing tyrosine phosphate; SIRP, signal regulatory protein.

A. Masuda and A. Nakamura contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS